Diagnostic Specialty Antibodies Market Worth $39.99 Billion By 2029

Diagnostic Specialty Antibodies Market by Type (Primary, Secondary), Clonality (Monoclonal, Polyclonal), Technique (WB, Rapid Test, IHC, IP), Conjugate, and Application (Dengue, Malaria, Hepatitis, HIV, E. coli , Tuberculosis, Pneumonia, Cancer)- Forecast to 2029

The Diagnostic Specialty Antibodies Market is expected to grow at a CAGR of 4.6% from 2022–2029 to reach $39.99 billion by 2029. Antibodies are used for therapeutic and diagnostic purposes. In diagnosis procedures, the sample containing antigens binds to the antibodies and assists in the diagnosis procedure. Diagnostic antibodies are used in the diagnosis of both infectious and chronic diseases. It is widely used in diagnosing cancer and infectious diseases. Additionally, it is used in pregnancy detection and for monitoring drug action in the body.

The increasing incidences of infectious diseases, cancer, autoimmune diseases, and pregnancy, the availability of funding for diagnosis of various diseases by different organizations, increasing number of fundings for clinical trials involving the use of diagnostic antibodies, and product approvals of test kits containing diagnostic antibodies are factors driving the growth of this market.

In addition, the high prevalence of diseases in emerging countries and the initiatives by the public and private organizations for improving the diagnosis activities for eradicating infectious diseases are expected to offer significant opportunities for the growth of this market.